[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363814-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363814-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","a-dleu2e2f1-regulatory-axis-promotes-migration-and-invasion-phenotypes-in-cervical-squamous-cell-carcinoma","A DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma","","Cervical squamous cell carcinoma (CSCC) is frequently diagnosed at advanced stages, where limited treatment efficacy makes the molecular drivers of metastasis critical. This study evaluates the role of long non-coding RNA DLEU2 in CSCC migration and invasion using RNA sequencing, functional assays, and regulatory network analyses. DLEU2 is upregulated in tumors and associates with poor prognosis. Mechanistically, E2F1 activates DLEU2, and a DLEU2/E2F1 regulatory axis promotes pro-migratory and pro-invasive phenotypes, regulating genes such as SNAI2 and MMP9.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/a-dleu2e2f1-regulatory-axis-promotes-migration-and-invasion-phenotypes-in-cervical-squamous-cell-carcinoma/363814/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/a-dleu2e2f1-regulatory-axis-promotes-migration-and-invasion-phenotypes-in-cervical-squamous-cell-carcinoma/363814.png","ImageObject",300,407,{"name":42,"@type":43},"Guten tag","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical problem does the study focus on?","Question",{"text":63,"@type":64},"It addresses cervical squamous cell carcinoma often being diagnosed at advanced stages, where limited treatment options make understanding metastasis mechanisms essential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What did the researchers find about DLEU2 expression?",{"text":68,"@type":64},"RNA sequencing showed DLEU2 is significantly upregulated in invasive CSCC tumors and its high expression correlates with poor prognosis in advanced-stage patients.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the DLEU2/E2F1 axis affect CSCC behavior?",{"text":72,"@type":64},"E2F1 transcriptionally activates DLEU2, and DLEU2 promotes migration and invasion; E2F1 overexpression rescues impairments caused by DLEU2 silencing.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363814,1790734052,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687212321768,"https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma  \nMin He1, Shiyi Huang3, Mingjiang Wang3, Tangrui Zhu4, Jinhua Ding1, Yitao Wang3, Mingbo Liu5,6􀀍 & Hanlu Wen2􀀍  \nCervical squamous cell carcinoma (CSCC), the most prevalent form of cervical cancer, is often diagnosed at advanced stages with limited treatment efficacy. Cell migration and invasion are critical steps, yet its molecular mechanisms remain poorly understood. This study investigates the role of the long non‑coding RNA DLEU2 inCSCC migration and invasion. RNA sequencing of 7 invasive CSCC and 7 normal cervical tissues revealed significant upregulation of DLEU2 in tumors, which correlated with poor prognosis in advanced‑stage patients. Functionally, DLEU2 knockdown suppressed, while its overexpression promoted, cancer cell migration and invasion in vitro. Mechanistically, we identified a DLEU2/E2F1 regulatory axis: E2F1 transcriptionally activates DLEU2, and DLEU2 in turn interacts with and may regulate E2F1 at transcription and post‑transcriptional level. Ectopic overexpression of E2F1 rescued the migratory and invasive impairments induced by DLEU2 silencing. Furthermore, DLEU2 regulated key migration and invasion‑related genes, including SNAI2 and MMP9. Together, our findings suggest an association between DLEU2 and E2F1 that may contribute to pro‑migratory and pro‑invasive phenotypes in CSCC, potentially offering this axis as a candidate therapeutic target.  \nKeywords lncRNA DLEU2, Cervical cancer, Migration, Invasion, E2F1  \nCervical cancer (CC) remains a major global health burden, ranking as the fourth most common cause of cancer-related mortality among women worldwide1. Invasive cervical squamous cell carcinoma (CSCC), which constitutes 70%–80% of all CC cases, is responsible for the majority of this morbidity and mortality2.  \nWhile persistent infection with high-risk human papillomavirus (HR-HPV) is the established etiological driver in nearly all cases, the progression to invasive and metastatic disease is governed by complex host molecular alterations3. Although widespread screening and HPV vaccination have improved early detection and prevention, a significant number of patients still present with advanced-stage disease3. While early-stage CSCC is often curable with surgery or radiotherapy, the therapeutic options for advanced or recurrent CSCC—primarily chemotherapy, immunotherapy, and targeted therapies—are limited in efficacy and associated with poor long-term survival4. Consequently, a deeper understanding of the molecular mechanisms that promote CSCC cell migration, invasion, and motility is imperative for developing more effective therapeutic strategies. In recent years, long non-coding RNAs (lncRNAs) have emerged as pivotal regulators in oncogenesis, critically influencing tumor growth, invasion, and metastatic dissemination5,6. Among these, the lncRNA DLEU2 has been implicated in the progression of diverse malignancies, positioning it as a potential pan-cancer biomarker and therapeutic target7. For instance, DLEU2 forms a regulatory loop with ROR1 to promote epithelial–mesenchymal transition (EMT) in breast cancer8, interacts with EZH2 to drive hepatocellular carcinoma proliferation9, and facilitates tumor cell infiltration in non-small cell lung cancer and pancreatic cancer10, 11. Furthermore, in gastric cancer, DLEU2 silencing suppresses invasion and migration by inhibiting the PI3K/AKT pathway12. Notably, within the context of cervical cancer, existing evidence indicates that DLEU2 contributes to cell proliferation13.  \n1Department of Obstetricsand Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. 2Jiulongpo District Center for Disease Control and Prevention, Chongqing, China. 3Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, ","cbCaimyykmtCQRgR","https://ap.wps.com/l/cbCaimyykmtCQRgR","pdf",10522519,14,"English","# Abstract\n# Introduction\n# Results\n## Analysis of differentially expressed genes in invasive CSCC","[{\"question\":\"What clinical problem does the study focus on?\",\"answer\":\"It addresses cervical squamous cell carcinoma often being diagnosed at advanced stages, where limited treatment options make understanding metastasis mechanisms essential.\"},{\"question\":\"What did the researchers find about DLEU2 expression?\",\"answer\":\"RNA sequencing showed DLEU2 is significantly upregulated in invasive CSCC tumors and its high expression correlates with poor prognosis in advanced-stage patients.\"},{\"question\":\"How does the DLEU2/E2F1 axis affect CSCC behavior?\",\"answer\":\"E2F1 transcriptionally activates DLEU2, and DLEU2 promotes migration and invasion; E2F1 overexpression rescues impairments caused by DLEU2 silencing.\"}]","A DLEU2/E2F1 regulatory axis promotes migration and invasion phenotypes in cervical squamous cell carcinoma | PDF",1790153375,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/effbd113110c5c35a05768836d7543a6.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3a3855c60eca29bc1deca04045b5739.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c88e3aeda799c74e464475950be7234f.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ebd536c06cf2ea53b5afdb1dc0c8566.webp",980,1287]